For healthcare professionals and researchers only. ClinicalMind content does not constitute clinical guidance, diagnosis, or treatment advice. See full disclaimer
Analysis and structured reporting on the healthcare AI market landscape — covering funding rounds, acquisitions, product launches, company failures, market sizing, adoption trends, and executive perspectives. Content in this group is explicitly labeled as industry analysis, not clinical evidence. Market statistics are always cited with source organization and methodology caveats. This group serves health system executives, investors, health IT strategists, and researchers tracking the commercial landscape. Excludes clinical evidence claims and does not present market projections as ground truth. Distinguishes between vendor-sourced data and independent research firm data. Links to relevant company profiles and clinical application entries where applicable.
A structured analysis of peer-reviewed evidence quantifying AI diagnostic performance gaps between lighter and darker skin tones in dermatology — including the root causes in training data composition, documented clinical consequences, and remediation strategies with published support — for clinicians, researchers, and health equity professionals evaluating AI skin diagnostic tools.
A structured digest of a 2025 npj Digital Medicine study in which NYC Health + Hospitals applied post-processing threshold adjustment to two live EMR classification models — reducing racial and insurance-based bias below pre-defined clinical thresholds without accessing model internals — offering a replicable playbook for resource-limited health systems.
